Nuclidium
SwitzerlandEntry
2025
Hold
1yr
Status
Active
Who owns Nuclidium?
Nuclidium is currently owned by Neva SGR through Neva II (2024 vintage), since 2025. Across its history, Nuclidium has been through 5 private equity ownership periods, detailed in the timeline below.
Hand-verified · updated 2026-04-21
Key takeaways
- ·Co-held by NRW.BANK, DeepTech & Climate Fonds, Angelini Ventures, Neva SGR and Wellington Partners since 2025.
- ·5 distinct PE sponsors across ownership cycles.
Ownership history
5 ownership periods · co-invest detected
Active
Co-held by NRW.BANK, DeepTech & Climate Fonds, Angelini Ventures, Neva SGR and Wellington Partners since 2025.
Co-invest · 4 holders · 2025 · present
NRW.BANKActive
2025 · present(1yr) · NRW.Venture · 2006 · VC
Neva SGRActive
2025 · present(1yr) · Neva II · 2024 · VC
Angelini VenturesActive
2025 · present(1yr) · Angelini Ventures · 2022 · Life Sciences VC
DeepTech & Climate FondsActive
2025 · present(1yr) · DeepTech & Climate Fonds · 2022 · Evergreen
Wellington PartnersActive
2026 · present(<1yr) · Wellington Partners Life Sciences · 1998 · VC
More from Neva II
Other portfolio companies in the same fund.
US
More PE-backed in Biotech
Comparable biotech deals from other GPs.
Track Nuclidium
Save this record to your watchlist and pick up your research where you left off. No spam.
Who could buy Nuclidium?
5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.
Find likely buyersGet the full record on Nuclidium.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue